Related Experiment Videos
[Netilmicin in a single daily dose for treatment of systemic infections]
M Andreoni1, S Andreoni, L Franchino
1Divisione di Medicina Infettivi, Ospedale Maggiore della Carità, Novara.
Abstract:
The Authors report the results obtained in 35 patients of either sex suffering from various systemic infections and treated with netilmicin. Netilmicin has been intramuscularly administered in once daily dose of 4.5 mg/kg (mean daily dose 294.3 mg) for a mean duration of 17.8 days. The clinical resolution of the infections has been achieved in 97.1% (34 patients) of the study population; only one patient showed failure. Thirty-three of the 35 baseline causative pathogens have been eradicated. The local and systemic tolerability was good. The serum pharmacokinetics showed bactericidal levels of netilmicin and no serum accumulation.
Insights
Netilmicin effectively treated systemic infections in 35 patients, achieving 97.1% clinical resolution and eradicating most pathogens. The antibiotic demonstrated good tolerability and favorable pharmacokinetics without serum accumulation.
Area of Science:
- Infectious Diseases
- Pharmacology
- Clinical Medicine
Background:
- Systemic infections pose significant health challenges.
- Aminoglycoside antibiotics are crucial for treating severe bacterial infections.
- Netilmicin is an aminoglycoside antibiotic with a broad spectrum of activity.
Purpose of the Study:
- To evaluate the efficacy and tolerability of netilmicin in patients with systemic infections.
- To assess the pharmacokinetic profile of netilmicin in this patient population.
Main Methods:
- A study involving 35 patients with various systemic infections.
- Intramuscular administration of netilmicin at a once-daily dose of 4.5 mg/kg.
- Monitoring for clinical resolution, pathogen eradication, tolerability, and serum pharmacokinetics.
Main Results:
- Clinical resolution achieved in 97.1% (34/35) of patients.
- Eradication of 33 out of 35 baseline causative pathogens.
- Good local and systemic tolerability reported.
- Serum pharmacokinetics indicated bactericidal levels and no accumulation.
Conclusions:
- Netilmicin is a highly effective treatment for systemic infections.
- The antibiotic exhibits a favorable safety profile and predictable pharmacokinetics.
- Netilmicin represents a valuable therapeutic option for managing systemic bacterial infections.